ProfileGDS4718 / 240299_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 13% 9% 8% 7% 6% 10% 14% 11% 8% 10% 7% 8% 6% 10% 9% 10% 9% 10% 12% 14% 8% 10% 9% 7% 5% 14% 10% 16% 7% 9% 8% 11% 10% 13% 5% 14% 11% 8% 11% 9% 8% 7% 8% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9887215
GSM549102patient 115, normal, homogenized [OPG study]3.9096513
GSM549104patient 119, normal, homogenized [OPG study]3.703669
GSM549108patient 138, normal, homogenized [OPG study]3.731578
GSM549119patient 077, normal, homogenized [OPG study]3.660027
GSM549133patient 032, cancer, homogenized [OPG study]3.607656
GSM549139patient 042, cancer, homogenized [OPG study]3.7565310
GSM549099patient 107, normal, homogenized [OPG study]3.9516214
GSM549109patient 139, normal, homogenized [OPG study]3.8600411
GSM549110patient 046, normal, homogenized [OPG study]3.721898
GSM549114patient 063, normal, homogenized [OPG study]3.7752910
GSM549122patient 082, normal, homogenized [OPG study]3.683737
GSM549134patient 033, cancer, homogenized [OPG study]3.713858
GSM549136patient 036, cancer, homogenized [OPG study]3.59416
GSM549140patient 044, cancer, homogenized [OPG study]3.7404510
GSM549111patient 047, normal, homogenized [OPG study]3.723789
GSM549113patient 057, normal, homogenized [OPG study]3.7609510
GSM549132patient 031, cancer, homogenized [OPG study]3.721889
GSM549137patient 038, cancer, homogenized [OPG study]3.7626110
GSM549142patient 047, cancer, homogenized [OPG study]3.9089512
GSM549100patient 110, normal, homogenized [OPG study]3.9200114
GSM549107patient 135, normal, homogenized [OPG study]3.670528
GSM549115patient 068, normal, homogenized [OPG study]3.7404110
GSM549116patient 072, normal, homogenized [OPG study]3.740459
GSM549120patient 078, normal, homogenized [OPG study]3.648917
GSM549131patient 030, cancer, homogenized [OPG study]3.549995
GSM549118patient 074, normal, homogenized [OPG study]3.9116714
GSM549129patient 027, cancer, homogenized [OPG study]3.7871810
GSM549123patient 088, normal, homogenized [OPG study]3.9811316
GSM549124patient 006, cancer, homogenized [OPG study]3.70627
GSM549126patient 015, cancer, homogenized [OPG study]3.710849
GSM549128patient 025, cancer, homogenized [OPG study]3.698188
GSM549103patient 117, normal, homogenized [OPG study]3.8356111
GSM549117patient 073, normal, homogenized [OPG study]3.779610
GSM549138patient 041, cancer, homogenized [OPG study]3.88213
GSM549141patient 045, cancer, homogenized [OPG study]3.521685
GSM549130patient 028, cancer, homogenized [OPG study]3.9255914
GSM549101patient 111, normal, homogenized [OPG study]3.8150511
GSM549105patient 128, normal, homogenized [OPG study]3.731168
GSM549106patient 134, normal, homogenized [OPG study]3.7728511
GSM549112patient 048, normal, homogenized [OPG study]3.740769
GSM549125patient 011, cancer, homogenized [OPG study]3.686518
GSM549127patient 024, cancer, homogenized [OPG study]3.655837
GSM549135patient 035, cancer, homogenized [OPG study]3.666888